Showing 1 - 20 results of 38,982 for search '(((( 1 mm decrease ) OR ( 50 ((c decrease) OR (_ decrease)) ))) OR ( _ web decrease ))*', query time: 0.99s Refine Results
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10

    mGluR5 receptor decreased glycinergic currents. by Zi-Yang Zhang (4988555)

    Published 2019
    “…(<b>F</b>) Postsynaptic loading of U-0126 or PD98059 prevented CHPG from decreasing glycinergic responses (U-0126, 107.6 ± 10.4% of baseline at 15–20 min post-CHPG, <i>t</i>[8] = 0.997, <i>p</i> = 0.348; PD98059, 93.1 ± 5.0% of baseline at 15–20 min post-CHPG, <i>t</i>[5] = 0.883, <i>p</i> = 0.418). …”
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17

    Predictive values of IC<sub>50</sub> in mM (FFAs) for vanadium compounds and <i>in vivo</i> observations IC<sub>50</sub> in mM (FFAs) and decreasing blood glucose level. by Elena V. Fedorova (603922)

    Published 2014
    “…<p>Predictive values of IC<sub>50</sub> in mM (FFAs) for vanadium compounds and <i>in vivo</i> observations IC<sub>50</sub> in mM (FFAs) and decreasing blood glucose level.…”
  18. 18

    MCP-1-deficiency decreased CD11c-expressing cells via impairing the production of ROS and decreased activation of PLCγ2, Akt, and ERK upon M-CSF stimulation in BMM. by Woon-Ki Kim (447798)

    Published 2013
    “…<p>BMMs from WT (open bar) and MCP-1-KO mice (oblique-lined bar) were incubated in the presence of M-CSF (30 ng/ml) with U73122 (10 µM), Akt inhibitor IV (0.3 µM), PD098059 (5 µM), DPI (50 nM), NAC (3 mM), or H<sub>2</sub>O<sub>2</sub> (300 µM) for 4 d (A). *, <i>P</i><0.05; ***, <i>P</i><0.001 compared with vehicle-treated WT cells. …”
  19. 19

    Skp2 inhibitor SKPin C1 decreased viability and proliferation of multiple myeloma cells and induced apoptosis by Ying Yang (24175)

    Published 2019
    “…In contrast, 50 μM SKPin C1 only marginally decreased viability of normal B lymphocytes in 12 h. …”
  20. 20